To create a therapeutic drug monitoring (TDM) unit to carry out the analytical determination in biological fluids of the anticonvulsant drugs used in the treatment of Dravet syndrome.
To create a therapeutic drug monitoring (TDM) unit to carry out the analytical determination in biological fluids of the anticonvulsant drugs used in the treatment of Dravet syndrome.
Characterization of the didys552 zebrafish mutant line (mutation in snc1lab gene) and set up of an efficacy drug screening assay using reference compounds.
Characterization of the didys552 zebrafish mutant line (mutation in snc1lab gene) and set up of an efficacy drug screening assay using reference compounds.
The Apoyodravet Association (AD) central pillars are social innovation, patient-oriented technology and the promotion of research in the service of disease modification.
If you want to stay updated on the INDRE international research network please...